Author:
Borovyk K., ,Rindina N.,Kravchun P.,Tabachenko O.,Yermak O.,Romanyuk M., , , , ,
Publisher
Danylo Halytskyi Lviv National Medical University
Reference14 articles.
1. 1. Parxomenko AN, Lutaj YaM, Irkin OI, Bely'j DA, Stepura AA, Kushnir SP i dr. Kliniko-anamnesticheskaya xarakteristika i techenie gospital'nogo perioda zabolevaniya u bol'ny'x molodogo vozrasta s ostry'm koronarny'm sindromom s e'levaciej segmenta ST. Ukraїns'kij Kardіologіchnij Zhurnal. 2018;4:31-39. (Russian).
2. In-hospital switching of oral P2Y12 inhibitor treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention: prevalence, predictors and short-term outcome;Alexopoulos;Am Heart J,2014
3. Clinical efforts to reduce myocardial infarct size - the next step;Braunwald;J Cardiovasc Pharm Ther,2011
4. 4. Brodie BR. Aspiration thrombectomy with primary PCI for STEMI: review of the data and current guidelines. J Invasive Cardiol.2011;22:2B-5B.
5. 5. Guan W, Lu H, Yang K. Choosing between ticagrelor and clopidogrel following percutaneous coronary intervention: A systematic review and Meta-Analysis (2007-2017). Medicine (Baltimore). 2018;97(43):e12978.